Author

Laura Amelinck

Primary ORCID profile (0009-0007-2914-8251 · 3 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Laura AmelinckiD3 papers · Ghent University

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Bieke BrouxiD· 1 shared Elien Van WonterghemiD· 1 shared Griet Van ImschootiD· 1 shared Ilse DewachteriD· 1 shared Janne VerreyckeniD· 1 shared Jonas CasteleiniD· 1 shared Junhua XieiD· 1 shared Lien Van HoeckeiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Bieke BrouxORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

IL-34 empowers regulatory T cells with novel non-canonical function to safeguard brain barrier integrity during neuro-inflammation.

Lien Van Hoecke, Janne Verreycken, Lore Van Acker, Laura Amelinck, Junhua Xie, Jonas Castelein, Elien Van Wonterghem, Griet Van Imschoot, Marlies Burgelman, Sarah Vanherle, Ilse Dewachter, Paulien Baeten, Bieke Broux, Roosmarijn E. Vandenbroucke

This study identifies IL-34 as a novel factor enabling regulatory T cells to maintain brain barrier integrity during neuro-inflammation, with implications for treating neurological disorders.

bioRxiv · Sep 9, 2024 · PreprintImmunology